Status:
COMPLETED
The Effects of Dexmedetomidine on Intravenous Anesthetic Requirements for Children Undergoing Dental Procedures
Lead Sponsor:
University of British Columbia
Conditions:
Anesthetic Sparing
Eligibility:
All Genders
2-10 years
Phase:
PHASE4
Brief Summary
The investigators propose to determine the propofol and remifentanil sparing effects of a single dose of dexmedetomidine in the dental population. The investigators plan to do this by performing a bli...
Detailed Description
Purpose: To determine an optimal dose of dexmedetomidine for its anesthetic sparing effect, without extending post-operative stay. Hypothesis: The investigators hypothesize that dexmedetomidine wil...
Eligibility Criteria
Inclusion
- ASA 1-2
- Elective dental surgery
- Planned general anesthesia with TIVA
- Age 2-10 years
Exclusion
- General anesthesia with inhalation induction
- Documented seizure disorder
- Cardiac disease
- Cardiac rhythm abnormalities
- Chronic hypertension
- Weight \< 5th centile or \> 95th centile for age
- Pre-operative administration of anxiolytics (such as benzodiazepines or opioid analgesics)
- Hypersensitivity to dexmedetomidine or any other study medication
Key Trial Info
Start Date :
March 14 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2021
Estimated Enrollment :
88 Patients enrolled
Trial Details
Trial ID
NCT03422978
Start Date
March 14 2018
End Date
April 1 2021
Last Update
April 22 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
BC Children's Hospital - Department of Anesthesia
Vancouver, British Columbia, Canada, V5Z 4V4